CINÉTICA DE LOS ANTICUERPOS IgG E IgM ANTI-CITOMEGALOVIRUS DESPUÉS DEL NACIMIENTO

Luis Emilio Carranza Quispe

Resumen


En el presente estudio se estudió la cinética de los anticuerpos IgM e IgG
anticitomegalovirus en suero de niños menores de un año que han nacido y hacen sus controles en el Hospital Santa María de Cutervo, Cajamarca, del periodo 2015-2016. El estudio se realizará con muestras de suero de 480 niños, las cuales serán procesados por la técnica de ELISA para la determinación de IgM e IgG específicas anti-citomegalovirus (anti-CMG). En resultados previos obtenidos en 70 muestras de donantes se encontró, que el 54 % (38) fueron donantes femeninos, ninguno reactivo a IgM anti-CMV y 95 % (36) reactivo a IgG anti-CMV. El 46 % (32) fueron donantes masculinos, ninguno reactivo a IgM anti-CMV y todos reactivos a IgG anti-CMV. Se determinó en el estudio previo de donantes de sangre que ninguno de ellos tiene infección reciente causada por citomegalovirus (como lo muestra IgM anti-CMV) pero un alto porcentaje (97 %) resultó reactivo para IgG anti-CMV.


Texto completo:

PDF

Referencias


Adjei, A.A.; Armah, H.B.; Narter-Olaga, E.G. 2006. Seroprevalence of Cytomegalovirus among some voluntary blood donors at the 37 Military Hospital, Accra, Ghana. Ghana Medicine Journal, 40: 99-104.

Adler, S.P. 1983. Transfusion-associated cytomegalovirus infections. Reviews of Infectious Diseases, 5: 977-993.

Alford, C.A.; Stagno, S.; Pass, R.F. & Britt, W.J. 1990. Congenital and perinatal cytomegalovirus infections. Reviews of Infectious Diseases, 12: 745-753.

Amy, J.; Clippinger, T.G.; Maguire, T & Alwine, J.C. 2011. Human Cytomegalovirus infection perinuclear localization during amino acid maintains mTOR activity and its deprivation. Journal of Virology, 85: 93699376.

Bate, S. L; Dollard, S. C. & Cannon, M. J. 2010. Cytomegalovirus sero prevale nee in the United States: The national health and nutrition examination surveys 1988- 2004. Infectious Diseases Society of America, 50, 1439-1447.

Benmarzouk-Hidalgo, O. J.; Cisneros, J. M.; Cordero, E.; Martín-Peña, A.; Sanchez, B.; Martin-Gandul, C.¡Gentil, M. A.; Gómez-Bravo, M. A.; Lage, E. & PérezRomero, P. 2011.

Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment.

Antimicrobial Agents Chemotherapy, 91,927-933.

Berardi, A.; Rossi, C.¡ Fiorini, V.; Rivi, C.¡ Vagnarelli, F.¡ Guaraldi, N.; Pietrosemoli, P.; Lazzarotto, T. & Ferrari, F. 2011. Severe acquired cytomegalovirus infection in a full- term, formula-fed infant: case report, BMC Pediatrics, 6, 52.

Boeckh, M. Geballe, A. P. 2011. Cytomegalovirus: pathogen, paradigm, and puzzle. The Journal Clinical Investigation, 121,1673-1680.

Bowden, R. A.; Sayers, M.; Flournoy, N.; New-ton, B.; Banaji, M.; Thomas, E. D. & Meyers, J.D. 1986. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. The New England Journal

of Medicine, 314, 1006-1010.

Bowden, R. A.; Slichter, S. J.; Sayers, M.; Weis-dorf, D.; Cays, M.; Schock, G.; Banaji,

M.; Haake, R.; Welk, K.; Fisher, L. & McCullough, J. 1995. A comparison of leukocytereduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfus ion-associated CMV infection after marrow trans-plant. Blood, 86, 3598-3603.

Bueno, J.; Ramil, C. & Green, M. 2002. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Paediatrics Drugs, 4(5), 279-90.

Cannon, M. J.; Schmid, D. S. & Hyde T. B. 2010. Review of cytomegalovirus sero prevale nee and demographic characteristics associated with infection.

Review in Medical Virology, 20, 202-13.

Chilet, M.; Aguilar, T.; Benet, I.; Belda, J.; Tormo, N.¡ Carbonell, J. A.; Clari, M. A.; Costa, E. & D. Navarro. 2010. Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. Journal of medical virology, 82, 1384-91.

Colugnati, F. A.; Staras, S. A.; Dollard, S. C. & Cannon, M. J. 2007. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC infectious diseases, 2, 70:71

de Jong, M. D.; Galasso, G. J.; Gazzard, B.; Griffiths, P. D.; Jabs, D. A.; Kern, E. R. & SpectorS. A. 1998. Summary of the II International Symposium on Cytomegalovirus. Antiviral research, 39, 141-162.

Drebber, U.; Hardt, A.; Dienes, H. P. & Odenthal, M. 2011. Cytomegalovirus. Pathologicalanatomical manifestations and detection methods. Der Pathologe, 32, 418-27.

Drew, W. L; Tegtmeier, G.; Alter, H. J.; Laycock, M. E.; Miner, R. C. & Busch M. P. 2003. Frequency and duration of plasma CMV viremia in sero-converting blood donors and recipients. Transfusion, 43, 309-313.

Gargouri, J.; Elleuch, H.; Karray, H.; Rekik, H. & Hammami, A. 2000. Prevalence of anti- CMV antibodies in blood donors in the Sfax region (value in blood transfusion). Médicale La Tunisie, 78, 512-517.

Gilbert, G. L.; Hayes, K.; Hudson, I. L. & James, J. 1989. Prevention of transfusionacquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. The Lancet, 1, 1228- 1231.

Griffiths, P. D. 2002. Strategies to prevent CMV infection in the neonate. Seminars in neonatology, 7, 293-299.

Gutiérrez-Salinas, J.; Carmona-García, R.; García-Ortiz, L.; Chima-Galán, M. C.;

Suástegui-Domínguez, S.; Espinosa-Elizondo, R. M.; Treviño-Mejia, A. J.; Garcia- Méndez, S. & Rivera-Badillo, M. E. 2010. Detección de infección asintomática por citomegalovirus en donadores voluntarios de sangre. Medicina Interna de México, 26, 109-115.

High, K. P. 2005. Chronic infection and frailty: surrogate markers, associations, and causality. Journal of the American Geriatrics Society, 53, 906-908.

Holland, P. V. & Schmitt, P. J. 1987. Standards for blood banks and transfusion services: Arlington VA: Committee on standards. American Association of Blood Banks, 30-31.

Jim, W. T; Shu, C. H.; Chiu, N. C.; Chang, J. H.; Hung, H. Y.; Peng, C. C.¡ Kao, H. A.; Wei, T. Y.; Chiang, C. L. & Huang, F. Y 2009. High cytomegalovirus load and prolonged virus excretion in breast milk increase risk for viral acquisition by very low birth weight infants. The Pediatric infectious disease journal, 28, 891 -894.

Jutte, J. C.; Wessels, E.; Anna, M. H.; Annemiek, A.; Vander, E.; Lisette, G.; Aloys, C. M. & Ann, C. T. 2012. Rapid Genotyping of Cytomegalovirus in Dried Blood Spots by Multiplex Real-Time PCR Assays Targeting the Envelope Glycoprotein gB and gH Genes. Journal of Clinical Microbiology, 50, 232.

Kothari, A.¡ Ramachandran, V. G.; Gupta, P.; Singh, B. & Talwar V. 2002. Sero prevale nee of cytomegalovirus among voluntary blood donors in Delhi, India. Journal of health, population, and nutrition, 20, 348-351.

Krajden, M.; Shankaran, P.; Bourke, C. & Lau, W. 1996. Detection of cytomegalovirus in blood donors by PCR using the digene SHARP signal system assay: effects of sample preparation and detection methodology.

Journal of Clinical Microbiology, 34, 29-33.

Kraat, Y. J., R. M. Hendrix, M. P. Landini, and C. A. Bruggeman. 1992. Comparison of four techniques for detection of antibodies to cytomegalovirus, Journal Clinic of Microbiology, 30, 522-524.

Luck, S. Sharland, M. 2009. Postnatal cytomegalovirus: innocent bystander or hidden problem?. Archives of disease in childhood. Fetal and neonatal edition. 94, 58-64. Miller, W. J.; McCullough, J.; Balfour, H.; Haake, R. J.; Ramsay N. K.; Goldman, A.; Bowman, R. & Kersey, J. 1991. Prevention of cytomegalovirus infection following bone marrow transplantations: a randomized trial of blood product screening.

Bone Marrow Transplant, 7, 227-234.

Narvios, A. B. & Lichtiger, B. 2001. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study. Haematologica, 86, 952.

Nichols, W. G.; Price, T. H.; Gooley, T.; Corey, L. & Boeckh, M. 2003. Transfusion transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood, 101,4195-4200.

Osawa, R. & Singh, N. 2009. Cytomegalovirus infection in critically ill patients: a systematic review. Critical Care, 13, 68.

Schmaltz, H. N.; Fried, L. P.; Xue, Q-L.; Walston, J.; Leng, S. X. & Semba, R. D. 2005. Chronic cytomegalovirus infection and inflammation are associated with prevalent, frailty in community dwelling older women. Journal of the American Geriatrics Society, 53, 747- 754.

Sóderberg Naucler-C. 2006. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?. Journal of Internal Medicine, 259, 219-246.

Staras, S. A.; Dollard, S. C.; Radford, K. W.; Flanders, W. D.; Pass, R. F. & Cannon, M. J. 2006. Seroprevalence of cytomegalovirus infection in the United States 1988-1994. Clinical Infectious Diseases, 43, 1143-1151.

Tegtmeier, G. E. 1989. Posttransfusion cytomegalovirus infections. Archives of Pathology & Laboratory Medicine, 113, 236-45.

Thiele, T.; Krüger, K.;, Zimmermann, K.; Ittermann, T.; Wessel, A.; Steinmetz, I.; Dolken, T. & Greinacher, A. 2011. Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a singlecenter prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME). Transfusion, 51,2620-2626.

Trincado, D. & Rawlinson, W. D. 2001. Congenital and perinatal infections with cytomegalovirus. Journal of Paediatrics and Child Health, 37, 187-192.

Wu, C. A.; Paveglio, S. A.; Lingenheld, E. G.; Zhu, L.; Lefrangois, L. & Lynn, P. 2011. Transmission of Murine Cytomegalovirus in Breast Milk: a Model of Natural Infection in Neonates. Journal of Virology, 85, 5115-5124.

Yeager, A. S. Grumet, F.C.; Hafleigh, E. B.; Arvin, A. M.; Bradley, J. S. & Prober, C. G. 1981. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. Journal of Pediatrics, 98, 281-287.




Contador de visitas: Resumen | 4 | y PDF | 0 |

Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2020 METANOIA: REVISTA DE CIENCIA, TECNOLOGÍA E INNOVACIÓN

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento 4.0 Internacional.

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.

 

http://revista.uniandes.edu.ec